Health Protection Agency. (30 September 2011, date last accessed)
Health Protection Agency. Mandatory surveillance of Clostridium difficile. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1179746015058 (30 September 2011, date last accessed).
Health Protection Agency. (30 September 2011, date last accessed)
Health Protection Agency. Clostridium difficile Ribotyping Network (CDRN) Service. http://www.hpa.org.uk/ProductsServices/InfectiousDiseases/LaboratoriesAndReferenceFacilities/ClostridiumDifficileRibotypingNetworkService/ (30 September 2011, date last accessed).
Health Protection Agency. (30 September 2011, date last accessed)
Health Protection Agency. Clostridium difficile Ribotyping Network (CDRN) for England and Northern Ireland 2009/2010 report 2009-10. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1296681523205 (30 September 2011, date last accessed).
Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality
Miller M, Gravel D, Mulvey M et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010; 50: 194-201.
Office for National Statistics. (30 September 2011, date last accessed)
Office for National Statistics. Deaths involving Clostridium difficile: England and Wales, 2006 to 2010. http://www.ons.gov.uk/ons/rel/subnational-health2/deaths-involving-clostridium-difficile/2006-to-2010/statistical-bulletin.html (30 September 2011, date last accessed).
NHS Purchasing and Supply Agency. (30 September 2011, date last accessed)
NHS Purchasing and Supply Agency. Evaluation report: Clostridium difficile toxin detection assays 2009. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_127743.pdf (30 September 2011, date last accessed).
Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England
Goldenberg SD, French GL. Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect 2011; 79: 4-7.
Impact of changes in Clostridium difficile diagnostic testing on detection of C
Chand MA, Fleming MJ, Wellsteed S et al. Impact of changes in Clostridium difficile diagnostic testing on detection of C. difficile infection and all Englandmandatory surveillance data. J Hosp Infect 2011; 79: 8-12.
Medicines and Healthcare Products Regulatory Agency. (30 September 2011, date last accessed)
Medicines and Healthcare Products Regulatory Agency. In vitro diagnostic medical devices directive. http://www.mhra.gov.uk/Howweregulate/Devices/InVitroDiagnosticMedicalDevicesDirective/index.htm (30 September 2011, date last accessed).
Food and Drug Administration. (30 September 2011, date last accessed)
Food and Drug Administration. Medical Devices: Overview of IVD regulation. http://www.fda.gov/medicaldevices/deviceregulationandguidance/ivdregulatoryassistance/ucm123682.htm (30 September 2011, date last accessed).
Department of Health, England. (30 September 2011, date last accessed)
Department of Health, England. High impact intervention: care bundle to reduce the risk from Clostridium difficile. http://hcai.dh.gov.uk/files/2011/03/Document_Clostridium_difficile_Infection_High_Impact_Intervention_FINAL_101210.pdf (30 September 2011, date last accessed).
Department of Health and the Health Protection Agency. (30 September 2011, date last accessed)
Department of Health and the Health Protection Agency. Clostridium difficile infection: How to deal with the problem. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1232006607827 (30 September 2011, date last accessed).